Exploring how cancer cells use nutrients for growth
Official title: Development and Implementation of Advanced Technologies for Cancer Metabolism Research
Funded at Sanford Burnham Prebys Medical Discovery Institute · NIH-10897179 · Data updated 2026-11-12
This study is looking at how cancer cells use nutrients like sugars and fats, using special technology to help find better ways to treat cancer, which could lead to more effective treatments for patients.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Sanford Burnham Prebys Medical Discovery Institute NIH-funded |
| Lab location | 1 site (La Jolla, United States) |
| Project start | August 1, 2023 |
| Project end | July 31, 2028 |
| Funding year | 2024 |
| Award (this year) | $142,032 |
| NIH project number | 5R50CA283813-02 |
| Project ID | NIH-10897179 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation or benefit from this research are individuals diagnosed with various types of cancer who are seeking innovative treatment options.
✕Less likely to help
Patients with non-cancerous conditions or those not currently undergoing treatment for cancer may not receive direct benefits from this research.
What this research studies
This research focuses on understanding cancer metabolism by utilizing advanced technologies to trace and quantify metabolites in cancer cells. The Cancer Metabolism Core at Sanford Burnham Prebys Medical Discovery Institute employs gas chromatography-mass spectrometry (GC-MS) to analyze how cancer cells process various nutrients, including fatty acids and sugars. By developing new methods for metabolite detection, the research aims to provide insights that could lead to improved cancer treatments and therapies. Patients may benefit from the findings as they could inform more effective strategies for targeting cancer metabolism.
Why it matters
Potential benefit: If successful, this research could lead to new therapeutic approaches that specifically target cancer cell metabolism, potentially improving treatment outcomes for patients.
How similar studies have gone: Previous research utilizing similar metabolite tracing techniques has shown promising results in understanding cancer biology and developing targeted therapies.
Where this research is happening
-
Sanford Burnham Prebys Medical Discovery Institute
La Jolla, United States Active
Researchers
- Principal investigator: Scott, David Anderson — Sanford Burnham Prebys Medical Discovery Institute
- Study coordinator: Scott, David Anderson
Related research
Other NIH-funded projects on the same topics.
-
Aging and liver cancer: new ways to prevent and fight hepatocellular carcinoma
This research explores how aging promotes liver cancer and tests new preventive approaches that could help people at higher risk due to age.
-
EPHA2 signaling and breast cancer spread tied to the body’s stiffness
This grant explores how the EPHA2 receptor helps breast cancer cells respond to the stiffness of their surroundings and whether activating EPHA2’s normal signaling can block cancer invasion.
-
Molecule-focused study on soluble TREM2 in Alzheimer's disease
A study to understand how soluble TREM2 in the brain and spinal fluid may influence Alzheimer's disease in people with the condition or at risk for it.
-
How NRF2 and FBP1 control liver metabolism
This work looks at whether changes in two liver proteins, NRF2 and FBP1, help explain low blood sugar and fat buildup in the liver for people with metabolic liver problems or rare FBP1 deficiency.
-
How mitochondrial and immune signals drive inflammation linked to Alzheimer's
This project looks at how damaged mitochondria and immune signaling cause inflammation that may contribute to Alzheimer's disease.
-
Nup210’s role in leukemia and its potential as a target
A doctor-scientist team is studying how a protein called Nup210 helps a type of blood cancer (AML) grow, with the goal of finding new ways to predict outcomes and treat the disease.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.